Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Patrick Mahaffey
Pharma
Will Clovis be the next PARP maker to get swallowed up?
Clovis is facing several challenges that have biopharma experts speculating it will be snapped up by an asset-hungry Big Pharma player.
Arlene Weintraub
Dec 7, 2018 10:32am
Clovis' Rubraca joins 'three-horse' race
Apr 9, 2018 12:26pm
With FDA priority review, Clovis eyes big new use for Rubraca
Dec 6, 2017 10:15am
ESMO: Clovis CEO hopes to hone Rubraca edge with new Ariel data
Sep 8, 2017 5:52am
